Manufacturing and Production
Merck KGaA manufacturing under scrutiny by FDA
March 27, 2012 Manufacturing and Production FDA, Merck KGaA, Rebif, Violations, manufacturing
FDA warns against phthalate use in medicines
March 27, 2012 Manufacturing and Production FDA, SUPAC, manufacturing, phthalates
HPI strengthens healthcare and pharma presence with new hire
March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
UCB nominates new board members
March 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members
Rare diseases – pharma’s new frontier
March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases
Working Life: Mike Crooks, UK general manager, Astellas
March 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life
GSK selects Ulverston for biopharma manufacturing hub
March 22, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing
Former Roche man Guido Magni joins Versant
March 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm
EMA completes review of Ben Venue-made drugs
March 19, 2012 Manufacturing and Production Ben Venue, EMA, cancer drugs, production
Ranbaxy sets sights on North African pharma market
March 19, 2012 Manufacturing and Production
Pharma manufacturing news in brief
March 19, 2012 Manufacturing and Production Recipharm, manufacturing, production
Meetings, bloody meetings
March 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Meetings, clinical trials
Updated set of mandatory Article 57(2) requirements for marketing authorisation holders
March 15, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates; EMA; Pharmacovigilance; PV
Dismay as Sanofi announces UK plant closure
March 15, 2012 Manufacturing and Production, Sales and Marketing Plavix, Sanofi, job losses, manufacturing
Europe’s pharma sector : living through the crisis
March 14, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Greece, Tonarelli, Witty, austerity, pharma
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
